Trends in antihypertensive drugs in the elderly: The decline of thiazides

Journal of Human Hypertension

Volumn 15, Issue 5, 2001, Pages 291-297

  Onder, Graziano ^a,b   Gambassi, G ^a,c   Landi, F ^a   Pedone, C ^a,c   Cesari, M ^a   Carbonin, P U ^a   Bernabei, R ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Diuretics; Elderly; Prescription pattern

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

AGE; AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DRUG CHOICE; DRUG INFORMATION; DRUG USE; DRUG UTILIZATION; DRUG WITHDRAWAL; ELDERLY CARE; FEMALE; FUNCTIONAL ASSESSMENT; GENDER; HEART DISEASE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; POPULATION RESEARCH; PRACTICE GUIDELINE; PREDICTION; PRESCRIPTION; SIDE EFFECT; STEADY STATE; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BENZOTHIADIAZINES; DIURETICS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HUMANS; HYPERTENSION; ITALY; LOGISTIC MODELS; MALE; PROBABILITY; PROGNOSIS; REGISTRIES; RISK ASSESSMENT; SAMPLING STUDIES; SODIUM CHLORIDE SYMPORTER INHIBITORS; TREATMENT OUTCOME;

EID: 0035035845     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001176     Document Type: Article

References (40)

1. Dannenberg AL, Garrison RJ, Kannel WB. Incidence of hypertension in the Framingham Study. Am J Public Health 1988; 78: 676-679.
2. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension 1994; 23: 275-285.
3. Psaty BM et al. Health outcomes associated with antihypertensive therapy used as first line agents: a systematic review and meta-analysis. JAMA 1997; 277: 739-745.
4. Gueyffier F et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men: a meta-analysis of individual patient data from randomized controlled trials. Ann Intern Med 1997; 126: 761-767.
5. Gambassi G et al. Prevalence, clinical correlates and treatment of hypertension in elderly nursing home residents. Arch Intern Med 1998; 158: 2377-2385.
6. SHEP Cooperative Research Group. Prevention on stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
7. Kostis JB et al, for the SHEP Cooperative Research Group. Prevention of hearth failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1997; 278: 212-216.
8. Dalhof B et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285.
9. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405-412.
10. Murlow C et al. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2000; 2: CD000028.
11. Psaty BM et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997; 277: 739-745.
12. Pahor M et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996; 348: 493-497.
13. Zuccala G et al. Use of calcium antagonists and need for perioperative transfusion in older patients with hip fracture: an observational study. Br Med J 1997; 314: 643-664.
14. Psaty BM et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620-625.
15. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1988 Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1988; 148: 1023-1038.
16. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-183.
17. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446.
18. Task Force on the Availability of Cardiovascular Drugs to the Medically Indigent. Report of the Task Force on the Availability of Cardiovascular Drugs to the Medically Indigent. Circulation 1992; 85: 849-860.
19. Drugs for hypertension. Med Lett Drugs Ther 1993; 35: 55-60.
20. Pahor M et al. Age and severe adverse drug reactions caused by nifedipine and verapamil. J Clin Epidemiol 1996; 49: 921-928.
21. Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing 1972; 1: 233-238.
22. PHS-HCFA. International Classification of Diseases, 9th rev. Public Health Service-Health Care Financing Administration, Washington DC, 1980.
23. Pahor M et al. Drug data coding and analysis in epidemiologic studies. Eur J Clin Epidemiol 1994; 10: 405-411.
24. Siegel D et al. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? JAMA 1997; 278: 1745-1748.
25. Manolio TA et al. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med 1995; 155: 1855-1860.
26. Fishkind D, Paris BE, Aronow WS. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice. J Am Geriatr Soc 1997; 45: 809-812.
27. Nelson CR, Knapp DA. Trends in antihypertensive drug therapy of ambulatory patients by US office-based physicians. Hypertension 2000; 36: 600-603.
28. Staessen JA et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-764.
29. Moser M. Why are physicians not prescribing Diuretics more frequently in the management of hypertension? JAMA 1998; 279: 1813-1816.
30. Monane M et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population based study in the elderly. Am J Hypertens 1997; 10: 697-704.
31. Phillip T et al. Randomised, double blind, multicentre comparison of hydroclorothiazide, atenol, nitredipine, and enalapril in antihypertensive treatment: results of the HANE study. Br Med J 1997; 315: 154-159.
32. Alderman MH, Madhavan S, Cohen H. Antihypertensive drug therapy: the effect of JNC criteria on prescribing pattern and patient status through the first year. Am J Hypertens 1996; 9: 413-418.
33. Pogue VA et al. New staging of fifth Joint National Commettee on the Detection, Evaluation and Treatment of High Blood Pressure alters assessment of the severity and treatment of hypertension. Hypertension 1996; 28: 713-718.
34. Wang TJ, Ausiello JC, Stafford RS. Tends in antihyportensive drug advertising, 1985-1996. Circulation 1999; 99: 2055-2057.
35. Moser M et al. Who really determines your patients' prescriptions? JAMA 1991; 265: 498-500.
36. West E, Newton J. Clinical guidelines: an ambitious national strategy. Br Med J 1997; 315: 324.
37. van Kraaij DJ, Jansen RW, Gribnau FW, Hoefnagels WH. Loop diuretics in patients aged 75 years or older: general practitioners' assessment of indications and possibilities for withdrawal. Eur J Clin Pharmacol 1998; 54: 323-327.
38. Allison ME, Shilliday I. Loop diuretic therapy in acute and chronic renal failure. J Cardiovasc Pharmacol 1993; 22 (Suppl 3): S59-S70.
39. Berlowitz DR et al. Inadequate management of blood pressure in a hypertensive population. N Engl Med J 1998; 339: 1957-1963.
40. Di Bari et al. Undertreatment of hypertension in community-dwelling older adults: a drug utilization study in Dicomano, Italy. J Hypertens 1999; 17: 1633-1640.